Concepedia

Margaret M. O’Neill

MM

Statistics

Publications

5

Citations

265

H-Index

5

Active since

2008

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (France)

Boehringer Ingelheim (Japan)

Margaret M. O’Neill is an author at Boehringer Ingelheim (United States) specializing in pharmacology, enzyme inhibition, and drug discovery.

Publications per year

2008–2015

5

Publications

5

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway

Revati J. Tatake, Margaret M. O’Neill, Charles A. Kennedy et al. · Biochemical and Biophysical Research Communications · 2008 · 158 citations

, , +9

Indole RSK inhibitors. Part 2: Optimization of cell potency and kinase selectivity

Thomas M. Kirrane, Stephen J. Boyer, Jennifer Burke et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 41 citations · Full text

, , +16

Indole RSK inhibitors. Part 1: Discovery and initial SAR

Stephen J. Boyer, Jennifer Burke, Xin Guo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 34 citations · Full text

, , +14

Mitigation of Off-Target Adrenergic Binding and Effects on Cardiovascular Function in the Discovery of Novel Ribosomal S6 Kinase 2 Inhibitors

Ryan M. Fryer, Akalushi Muthukumarana, Rong Rhonda Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 18 citations

, , +17

The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury

Xi Shi, Margaret M. O’Neill, Scott M. MacDonnell et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2015 · 14 citations

, , +13

1–5 of 5